{
    "2018-08-08": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Unloved High-Yielders That Will Rise With Rates (and Pay Up to 7% in Cash!)",
                "features": {
                    "keywords": [
                        "High-Yielders",
                        "Rise",
                        "Rates",
                        "Cash"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-07-26",
                "original_text": "How Jazz Pharmaceuticals’ Products Performed in the Second Quarter",
                "features": {
                    "keywords": [
                        "Jazz Pharmaceuticals",
                        "Products",
                        "Second Quarter",
                        "Performance"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-09",
                "original_text": "New Novan incentive plan targets share price goals and $25M, $50M bonus pools",
                "features": {
                    "keywords": [
                        "Novan",
                        "incentive plan",
                        "share price",
                        "bonus pools"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-02",
                "original_text": "These Products Contributed to Pfizer’s Growth in Q2 2018",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Products",
                        "Growth",
                        "Q2 2018"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-09",
                "original_text": "Novan Provides Business Update via 10-Q, Adopts Incentive Plan and Agrees to CEO Contract",
                "features": {
                    "keywords": [
                        "Novan",
                        "Business Update",
                        "10-Q",
                        "Incentive Plan",
                        "CEO Contract"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-26",
                "original_text": "The Swiss Stock Market Pulled Back On Roche Weakness",
                "features": {
                    "keywords": [
                        "Swiss Stock Market",
                        "Pulled Back",
                        "Roche",
                        "Weakness"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}